110 related articles for article (PubMed ID: 2261379)
1. Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
Díaz-Rubio E; González-Larriba JL; Rosell R; Abad A; Martín M; Valerdi JJ; Barriga JJ
Ann Oncol; 1990 Sep; 1(5):379-80. PubMed ID: 2261379
[No Abstract] [Full Text] [Related]
2. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
[TBL] [Abstract][Full Text] [Related]
3. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
[TBL] [Abstract][Full Text] [Related]
4. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
Clerico M; Bertetto O; Morandini MP; Cardinali C; Giaccone G
Tumori; 1993 Apr; 79(2):119-22. PubMed ID: 8346563
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
Ell C; König HJ; Brockmann P; Domschke S; Domschke W
Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
8. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
9. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
Saito H; Amano H; Yasuda Y; Tsunekawa H; Fujimoto K; Yoshii S; Shimokata K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
[TBL] [Abstract][Full Text] [Related]
10. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
Mori K; Saito Y; Tominaga K
Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Bella M; Passalacqua R; Morsia D; DiCostanzo F; Donati D; Ballatori E; Tognoni G
J Clin Oncol; 1987 Jan; 5(1):141-9. PubMed ID: 3543234
[TBL] [Abstract][Full Text] [Related]
12. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
[TBL] [Abstract][Full Text] [Related]
13. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Fujii M; Kiura K; Tamai M; Okabe K; Toki H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
Lee CW; Suh CW; Lee JS; Lee KH; Cho GY; Kim SW; Kim SH
J Korean Med Sci; 1994 Oct; 9(5):369-75. PubMed ID: 7702784
[TBL] [Abstract][Full Text] [Related]
16. Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
Basurto C; Roila F; Tonato M; Ballatori E; Buzzi F; Calabresi F; Del Favero A
Am J Clin Oncol; 1989 Jun; 12(3):235-8. PubMed ID: 2729180
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
Grunberg SM; Akerley WL; Krailo MD; Johnson KB; Baker CR; Cariffe PA
Cancer Invest; 1986; 4(5):379-85. PubMed ID: 3801953
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
Malik I; Moid I; Khan Z; Hussain M
Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
[TBL] [Abstract][Full Text] [Related]
20. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
Senn HJ; Glaus A; Bachmann-Mettler I
J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
